Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7279
Rank
S$0.72 B
Marketcap
S$20.60
Share price
-0.33%
Change (1 day)
-48.09%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of March 2026 : S$0.21 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are S$0.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$0.20 B7.62%
2024-12-31S$0.19 B19.54%
2023-12-31S$0.15 B